等待開盤 09-11 09:30:00 美东时间
-0.070
-0.22%
Enovis Corporation (NYSE: ENOV) has announced its participation in the Baird 2025 Global Healthcare Conference on September 10, 2025, at 2:35 p.m. ET. A live audio webcast and replay will be available on the Company’s website under the Investors tab. Enovis, an innovation-driven medical technology company, focuses on developing solutions that improve patient outcomes and workflows. Its common stock is listed on the New York Stock Exchange under E...
09-08 20:05
Enovix Corporation successfully completed its warrant dividend program as all outstanding warrants expired or were exercised by August 29, 2025. Approximately 26.5 million warrants were exercised, generating about $232.1 million in gross proceeds, enhancing the company's capital position to expand its 100% silicon-anode battery technology, accelerate production, and explore acquisitions in the battery sector. The program concluded with no further...
09-05 22:08
Enovix AI-1TM smartphone battery achieves record-breaking energy density and fast charging, validated by Polaris Battery Labs. Capable of 919 Wh/L and 3C fast charging, Enovix targets the multi-billion-dollar smartphone market with advanced silicon battery technology, positioning itself as a leader in high-performance energy storage solutions.
08-27 12:30
Enovix Corporation appoints J. Daniel "Dan" McCranie to its Board of Directors, expanding the Board to eight members, six of whom are independent. McCranie, with over three decades of experience in public-company governance and leadership in the semiconductor and technology sectors, brings significant expertise to Enovix. His strategic insights will support the company's commercialization and manufacturing expansion. McCranie has held senior role...
08-14 12:52
今日重点评级关注:RBC Capital:维持Edgewise Therapeutics"跑赢大市"评级,目标价从48美元升至49美元;RBC Capital:维持Nuvation Bio"跑赢大市"评级,目标价从6美元升至7美元
08-11 09:43
Wells Fargo analyst Vik Chopra maintains Enovis (NYSE:ENOV) with a Overweight and lowers the price target from $48 to $41.
08-08 23:21
Enovis shares are trading higher after the company reported better-than-expecte...
08-07 18:49
2025 Financial OutlookEnovis updated financial expectations for 2025. Revenue is expected to be in the range of $2.245-2.275 billion, versus prior expectations of $2.220-2.250 billion. Adjusted EBITDA is forecasted to be
08-07 18:04
Companies Reporting Before The Bell • GoHealth (NASDAQ:GOCO) is estimated to re...
08-07 16:33
Enovix Corporation announced that its common stock price has exceeded $10.50 for 9 consecutive trading days since the distribution of warrants (ENVXW). The warrants remain $1.96 in-the-money with an exercise price of $8.75. The earliest expiration date is August 19, 2025, contingent on the stock trading above $10.50 for 20 of 30 trading days. CFO Ryan Benton noted that only 11 trading days may remain before expiration, encouraging shareholders to...
08-01 20:59